Participants 105 129 5
resectable rectal cancer
Participants 302 314 6
ectal cancer
Participants 383 404 6
multicentre phase-III
Participants 405 471 6
European Organization for Research and Treatment of Cancer (EORTC)
Participants 488 587 4
Twelve radiotherapy departments with more than 10% of the evaluable patients recruited in the trial
Participants 930 958 3
5 patients per institution w
